P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans
Overview
Affiliations
Purpose: To report the prevalence and risk factors for retinopathy in African Americans with impaired fasting glucose (IFG) and type 2 diabetes in the Jackson Heart Study and to determine if P-selectin plasma levels are independently associated with retinopathy in this population.
Design: Prospective, cross-sectional observational study.
Methods: setting: Community-based epidemiologic study.
Study Population: Total of 629 patients with type 2 diabetes and 266 participants with impaired fasting glucose.
Observation Procedures: Bilateral, 7-field fundus photographs were scored by masked readers for diabetic retinopathy (DR) level. Covariate data including P-selectin plasma levels and genotypes were collected in a standardized fashion.
Main Outcome Measures: Association between risk factors, including P-selectin plasma levels and genotypes, and retinopathy.
Results: The prevalences of any retinopathy among participants with IFG and type 2 diabetes were 9.4% and 32.4%, respectively. Among those with type 2 diabetes, in multivariate models adjusted for age, sex, and other traditional risk factors, higher P-selectin levels were associated with any DR (odds ratio = 1.11, 95% confidence interval = 1.02-1.21, P = .02) and proliferative DR (odds ratio = 1.23, 95% confidence interval = 1.03-1.46, P = .02). To further investigate the relationship between P-selectin and DR, we examined the association between P-selectin genotype and DR. Minor allele homozygotes for the variant rs6128 were less likely to develop DR (P after Bonferroni correction = 0.03).
Conclusions: Both serologic and genetic data show an association between P-selectin and DR in the Jackson Heart Study. If confirmed in other studies, this association may provide insight into the pathogenesis of retinopathy.
Prevalence of Retinopathy in Prediabetic Populations: A Systematic Review and Meta-Analysis.
Sune M, Sune M, Sune P, Dhok A Cureus. 2024; 15(11):e49602.
PMID: 38161917 PMC: 10755086. DOI: 10.7759/cureus.49602.
The Role of Genetic Polymorphisms in Diabetic Retinopathy: Narrative Review.
Sienkiewicz-Szlapka E, Fiedorowicz E, Krol-Grzymala A, Kordulewska N, Rozmus D, Cieslinska A Int J Mol Sci. 2023; 24(21).
PMID: 37958858 PMC: 10650381. DOI: 10.3390/ijms242115865.
Alterations in factors associated with diabetic retinopathy combined with thrombosis: A review.
Wei H, Xiao X, Zeng S, Liu Y, Liu X, Zeng T Medicine (Baltimore). 2023; 102(31):e34373.
PMID: 37543800 PMC: 10403020. DOI: 10.1097/MD.0000000000034373.
Long Noncoding RNAs and Mitochondrial Homeostasis in the Development of Diabetic Retinopathy.
Kowluru R Front Endocrinol (Lausanne). 2022; 13:915031.
PMID: 35733767 PMC: 9207305. DOI: 10.3389/fendo.2022.915031.
Gene Set Enrichment Analsyes Identify Pathways Involved in Genetic Risk for Diabetic Retinopathy.
Sobrin L, Susarla G, Stanwyck L, Rouhana J, Li A, Pollack S Am J Ophthalmol. 2021; 233:111-123.
PMID: 34166655 PMC: 8678352. DOI: 10.1016/j.ajo.2021.06.014.